Funded Startups in Kongens Lyngby
Across these 11 most recent listings for Kongens Lyngby, the largest disclosed round is NIL Technology ApS at $31M (2024-05-07).
Across these 11 most recent listings for Kongens Lyngby, the largest disclosed round is NIL Technology ApS at $31M (2024-05-07). That amount sits in the same general band as other larger disclosed rounds like Aquaporin at $25M (2024-04-25) and Reshape Biotech at $20M (2024-04-09), while several others cluster far below, including ENZIDIA at $240K (2026-03-16) and the $2M round for Droplet IV (2025-06-17). Several entries also cluster in spring 2024: four rounds (Aquaporin on 2024-04-25, Reshape Biotech on 2024-04-09, Konsolidator on 2024-05-03, and NIL Technology ApS on 2024-05-07) fall within about a month, suggesting a concentrated financing window within this slice.
Sector-wise, biotechnology appears most frequently with 3 entries (ENZIDIA 2026-03-16, Aquaporin 2024-04-25, Rehaler 2023-06-23). Stage labels are split, with 3 of 11 rows marked “Series Unknown” (NIL Technology ApS at $31M is “Series Unknown,” Konsolidator at $850K is “Series Unknown,” and Aquaporin is “Series Unknown”), plus 2 rows with undisclosed amounts (AgriRobot on 2024-12-11 and Rehaler on 2023-06-23). The dated range runs from 2021-04-09 (Abzu, $6M) through the most recent entry on 2026-03-16 (ENZIDIA, $240K).
Most recent rounds
11 shownRelated listings
Frequently asked
What’s the largest disclosed round in Kongens Lyngby here, and how does it compare to nearby disclosed deals?
The largest disclosed amount is NIL Technology ApS at $31M on 2024-05-07. That $31M level is close to other larger disclosed rounds such as Aquaporin ($25M on 2024-04-25) and Reshape Biotech ($20M on 2024-04-09), while several disclosed deals are much smaller (e.g., ENZIDIA $240K on 2026-03-16; Konsolidator $850K on 2024-05-03).
Do any sectors or categories appear over-represented in this set of 11?
Biotechnology shows up 3 times (ENZIDIA on 2026-03-16, Aquaporin on 2024-04-25, and Rehaler on 2023-06-23). Other repeated labels are less frequent in this slice, with AI appearing 2 times (Reshape Biotech on 2024-04-09 and Abzu on 2021-04-09).
Is there a financing cluster by date in this list?
Yes. Four disclosed rounds fall within roughly a month in spring 2024: Reshape Biotech ($20M, 2024-04-09), Aquaporin ($25M, 2024-04-25), Konsolidator ($850K, 2024-05-03), and NIL Technology ApS ($31M, 2024-05-07).
Which recent entries fall closest to the latest date shown?
The newest round is ENZIDIA on 2026-03-16 ($240K). In the more recent window after 2025-06-17, Droplet IV closed on 2025-06-17 ($2M), while no other entries appear between that date and ENZIDIA in this 11-row view.
Are there stage-label or disclosure outliers that stand out for diligence?
Disclosure isn’t uniform: 2 of 11 rows are “undisclosed” amounts (AgriRobot on 2024-12-11 and Rehaler on 2023-06-23). Separately, 3 of 11 rows use “Series Unknown” classifications (Konsolidator on 2024-05-03 at $850K; Aquaporin on 2024-04-25 at $25M; NIL Technology ApS on 2024-05-07 at $31M).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.